United Nations Mandate RegistryBeta Version
UN Secretariat ViewUN System ViewFocal points
(opens in new tab)
  • (opens in new tab)
  • (opens in new tab)
  • (opens in new tab)
  • (opens in new tab)
  • (opens in new tab)
Donate (opens in new tab)
  • A-Z Site Index (opens in new tab)
  • Contact (opens in new tab)
  • Copyright (opens in new tab)
  • FAQ (opens in new tab)
  • Fraud Alert (opens in new tab)
  • Privacy Notice (opens in new tab)
  • Terms of Use (opens in new tab)

International Cooperation to Ensure Global Access to Medicines, Vaccines and Medical Equipment to Face Covid-19

A/RES/74/274View PDF

Who adopted this document and its mandates?

A Resolution of the General Assembly, under agenda item 123 Strengthening of the United Nations System, published in 2020.

What subjects does this mandate have?

5 subjects
Covid-19International CooperationMedical EquipmentPharmaceuticalsVaccines

What’s in this document?

5 operative paragraphs
1
Reaffirms the fundamental role of the United Nations system in coordinating the global response to control and contain the spread of the coronavirus disease (COVID-19) and in supporting Member States, and in this regard acknowledges the crucial leading role played by the World Health Organization;
2
Requests the Secretary-General, in close collaboration with the World Health Organization and other relevant agencies of the United Nations system, including the international financial institutions, to identify and recommend options, including approaches to rapidly scaling manufacturing and strengthening supply chains that promote and ensure fair, transparent, equitable, efficient and timely access to and distribution of preventive tools, laboratory testing, reagents and supporting materials, essential medical supplies, new diagnostics, drugs and future COVID-19 vaccines, with a view to making them available to all those in need, in particular in developing countries;
3
Encourages Member States to work in partnership with all relevant stakeholders to increase research and development funding for vaccines and medicines, leverage digital technologies, and strengthen scientific international cooperation necessary to combat COVID-19 and to bolster coordination, including with the private sector, towards rapid development, manufacturing and distribution of diagnostics, antiviral medicines, personal protective equipment and vaccines, adhering to the objectives of efficacy, safety, equity, accessibility, and affordability;
4
Calls upon Member States and other relevant stakeholders to immediately take steps to prevent, within their respective legal frameworks, speculation and undue stockpiling that may hinder access to safe, effective and affordable essential medicines, vaccines, personal protective equipment and medical equipment as may be required to effectively address COVID-19;
5
Requests the Secretary-General, in close collaboration with the World Health Organization, to take the necessary steps to effectively coordinate and follow up on the efforts of the United Nations system to promote and ensure global access to medicines, vaccines and medical equipment needed to face COVID-19, and, in this regard, to consider establishing, within existing resources, an inter-agency task force, and to brief the General Assembly on such efforts, as appropriate.
20 April 2020

Table of contents

No headings found in this document.